124 related articles for article (PubMed ID: 12835851)
1. [Gene therapy with p53 tumor suppressors].
Dietz A; Esser D; Helbig M; Bosch FX
HNO; 2003 May; 51(5):365-8. PubMed ID: 12835851
[No Abstract] [Full Text] [Related]
2. [Experimental research on gene therapy and transfer on head and neck cancer in the course of a multimodal therapy concept].
Lang S
Laryngorhinootologie; 2002 Jul; 81(7):534-5. PubMed ID: 12173066
[No Abstract] [Full Text] [Related]
3. [Examinations on the importance of the inactivation of the tumor suppressor gene p16, reactivation of the telomerase and mutation of p53 in the pathogenesis of head and neck tumors].
Koscielny S
Laryngorhinootologie; 2003 Mar; 82(3):197-8. PubMed ID: 12673521
[No Abstract] [Full Text] [Related]
4. Survivin multifaceted activity in head and neck carcinoma: current evidence and future therapeutic challenges.
Marioni G; D'Alessandro E; Bertolin A; Staffieri A
Acta Otolaryngol; 2010; 130(1):4-9. PubMed ID: 19322702
[TBL] [Abstract][Full Text] [Related]
5. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].
Bosch FX; Homann N; Conradt C; Dietz A; Erber R
HNO; 1999 Sep; 47(9):833-48. PubMed ID: 10525616
[No Abstract] [Full Text] [Related]
6. [Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].
Kunz C; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
HNO; 2003 Oct; 51(10):800-5. PubMed ID: 14523533
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for head and neck cancer.
Frank DK
Surg Oncol Clin N Am; 2002 Jul; 11(3):589-606, vi-vii. PubMed ID: 12492081
[TBL] [Abstract][Full Text] [Related]
8. Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization.
Ndoye A; Dolivet G; Høgset A; Leroux A; Fifre A; Erbacher P; Berg K; Behr JP; Guillemin F; Merlin JL
Mol Ther; 2006 Jun; 13(6):1156-62. PubMed ID: 16564229
[TBL] [Abstract][Full Text] [Related]
9. [IL-2 gene therapy in ENT carcinomas].
Lang S; Zeidler R; Pauli C; Andratschke M; Wollenberg B
Laryngorhinootologie; 2001 Apr; 80(4):191-5. PubMed ID: 11383120
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity in mammary serine protease inhibitor (maspin) and p53 at chromosome 17 and 18 in oral cavity squamous cell carcinoma.
Choi KY; Choi HJ; Chung EJ; Lee DJ; Kim JH; Rho YS
Head Neck; 2015 Sep; 37(9):1239-45. PubMed ID: 24801268
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for head and neck cancer.
Gleich LL
Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
[TBL] [Abstract][Full Text] [Related]
12. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck.
Gleich LL; Gluckman JL; Nemunaitis J; Suen JY; Hanna E; Wolf GT; Coltrera MD; Villaret DB; Wagman L; Castro D; Gapany M; Carroll W; Gillespie D; Selk LM
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):775-9. PubMed ID: 11448348
[TBL] [Abstract][Full Text] [Related]
14. [Development, current status and perspectives of tumor therapy in oromandibulofacial surgery--a determination of the current status].
Hausamen JE; Eckardt A; Schmelzeisen R
Fortschr Kiefer Gesichtschir; 1994; 39():5-12. PubMed ID: 8088670
[No Abstract] [Full Text] [Related]
15. [Tumor after-care: goals, results and concepts].
Haas I
Laryngorhinootologie; 2000 Nov; 79(11):667-8. PubMed ID: 11138508
[No Abstract] [Full Text] [Related]
16. [15 years of oncology at the ENT Clinic of Lausanne].
Monnier P; Brossard E; Pasche P; Pasche R; Ollyo JB; Pellissier S; Fontolliet C
Rev Med Suisse Romande; 1992 Jan; 112(1):19-26. PubMed ID: 1535956
[No Abstract] [Full Text] [Related]
17. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.
Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
Acta Otolaryngol; 2012 Sep; 132(9):1006-12. PubMed ID: 22667340
[TBL] [Abstract][Full Text] [Related]
18. [p53 gene therapy for oral cancer].
Liu SX; Hu M
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Sep; 47(9):569-72. PubMed ID: 23141735
[No Abstract] [Full Text] [Related]
19. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
Edelman J; Edelman J; Nemunaitis J
Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
